Combinations of substituted azetidonones and cb1 antagonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/397 (2006.01) A61K 31/4155 (2006.01) A61P 3/04 (2006.01)

Patent

CA 2581596

The present invention provides compositions, therapeutic combinations and methods including: (a) at least one selective CB1 antagonist; and (b) at least one substituted azetidinone or substituted .beta.-lactam sterol absorption inhibitor which can be useful for treating vascular conditions, diabetes, obesity, metabolic syndrome and lowering plasma levels of sterols or 5.alpha.- stanols.

La présente invention concerne des compositions, des combinaison et des méthodes thérapeutiques, dans lesquelles sont utilisés (a) au moins un antagoniste CB1 sélectif et (b) au moins une azétidinone substituée ou un inhibiteur d'absorption des .beta.-lactames stérols substitué, pouvant être utilisées pour traiter les troubles vasculaires, le diabète, l'obésité et le syndrome métabolique et pour réduire la concentration plasmique en stérols ou en 5.alpha.-stanols.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combinations of substituted azetidonones and cb1 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combinations of substituted azetidonones and cb1 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of substituted azetidonones and cb1 antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1430800

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.